May 19, 2023
CMTC Helps In-Vitro Diagnostic Substance Manufacturer Expand Their Market with Sales & Marketing Support
Apr 17, 2023
Integrated DNA Technologies Launches New Archer™ FUSIONPlex™ Core Solid Tumor Panel for Cancer Research
Apr 11, 2023
CivicaScript™, SortPak partner to package & deliver medicines to maximize patient convenience, compliance and savings
Mar 28, 2023
Integrated DNA Technologies Bolsters Leadership Team, Adds New Global Head of Commercial
Mar 21, 2023
BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey
Mar 08, 2023
Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
Mar 06, 2023
Resolution Medical Appoints Peter Herman as Chief Executive Officer
Mar 01, 2023
Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments
Feb 22, 2023
Kite Completes Acquisition of Tmunity
Feb 15, 2023
Humanetics Corporation Announces Positive Results from Independent Data Monitoring Committee Review of Phase 2 Clinical Trial
Feb 15, 2023
End Drug Shortages Alliance Finds Care for Bladder Cancer Patients Impacted by Drug Shortage
Feb 09, 2023
DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by the Veterans Health Administration
Feb 01, 2023
BWXT Medical and Laurentis Complete Key Tc-99m Generator Program Milestone
Jan 13, 2023
Global Market Forecasts for Immuno-Oncology Diagnostics, 2023-2028 - Explosion in Immuno-oncology Therapies Creates an Exploding Diagnostic Market - ResearchAndMarkets.com
Jan 10, 2023
DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by TRICARE
Jan 06, 2023
Fusion Pharmaceuticals and BWXT Medical Announce Actinium-225 Partnership to Scale Supply for Developing Targeted Alpha Therapies
Dec 13, 2022
Chimeron Bio Welcomes Kevin Heyeck as New CEO
Dec 09, 2022
Kite and Arcellx Announce Strategic Collaboration to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma
Dec 08, 2022
Bertis Announces Research Results of AI-based Disease Diagnosis Model in the World’s Largest Academic Event in Proteomics
Dec 02, 2022
PGT Innovations shows support for four breast cancer non-profits with donation totaling over $9,000